Clearstead Advisors’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.4K Hold
965
﹤0.01% 1742
2026
Q1
$21.1K Sell
965
-1,514
-61% -$35.1K ﹤0.01% 1445
2025
Q4
$57.7K Buy
2,479
+437
+21% +$10.5K ﹤0.01% 1344
2025
Q3
$57.8K Buy
2,042
+922
+82% +$24.5K ﹤0.01% 1236
2025
Q2
$24.6K Buy
1,120
+870
+348% +$19K ﹤0.01% 1534
2025
Q1
$5.83K Hold
250
﹤0.01% 1720
2024
Q4
$7.18K Hold
250
﹤0.01% 1655
2024
Q3
$7.42K Hold
250
﹤0.01% 1642
2024
Q2
$8.43K Sell
250
-4,565
-95% -$158K ﹤0.01% 1575
2024
Q1
$167K Sell
4,815
-35
-0.7% -$1.21K 0.01% 498
2023
Q4
$158K Sell
4,850
-4,850
-50% -$150K 0.01% 490
2023
Q3
$316K Buy
9,700
+4,850
+100% +$155K 0.01% 474
2023
Q2
$142K Hold
4,850
0.01% 494
2023
Q1
$136K Hold
4,850
0.01% 453
2022
Q4
$132K Hold
4,850
0.01% 449
2022
Q3
$116K Hold
4,850
0.01% 452
2022
Q2
$136K Hold
4,850
0.01% 440
2022
Q1
$141K Sell
4,850
-940
-16% -$29.2K 0.01% 478
2021
Q4
$202K Buy
5,790
+4,850
+516% +$172K 0.01% 386
2021
Q3
$31K Buy
+940
New +$30.4K ﹤0.01% 696

Other funds holding GNTX

Clearstead Advisors's GNTX Position: Q2 2026 in Review

Clearstead Advisors held its Gentex (GNTX) position steady in Q2 2026 at 965 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1742.

Clearstead Advisors first reported a position in GNTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $316K in Q3 2023. 528 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Clearstead Advisors held 965 shares of Gentex worth $24.4K as of Q2 2026.
  • Clearstead Advisors left its Gentex share count unchanged in Q2 2026.
  • Gentex made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1742 holding.
  • Clearstead Advisors first reported a position in Gentex in Q3 2021 and has held it in 20 quarters since.
  • Clearstead Advisors's Gentex position peaked at $316K in Q3 2023.
  • 528 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.